Lilly Sues Hetero To Block Generic Strattera
By Abigail Rubenstein ( June 9, 2011, 1:06 PM EDT) -- Eli Lilly & Co. filed suit in New Jersey on Monday in an effort to keep India's Hetero Drugs Ltd. from launching a generic version of attention deficit hyperactivity disorder treatment Strattera in the U.S....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.